Research › Epilepsy & Seizures
Evidence-Based Biofeedback and Neurofeedback for People with Epilepsy and Seizures
STS Instructor Authored by Robert Turner
Share
Study at a glance
- Area
- Epilepsy & Seizures
- Study type
- Review & meta-analysis
- Authors
- Turner RP
- Journal
- Policy Insights from the Behavioral and Brain Sciences
- Year
- 2022
- Protocol
- biofeedback and neurofeedback for seizure control
Key findings
- Notes that medication and surgery often fail to stop seizures completely
- Describes biofeedback and neurofeedback as non-invasive, low-risk and low-cost
- Literature review covering the 1960s to the present found 150 articles reporting seizure and EEG/QEEG improvements
- Recommends biofeedback and neurofeedback as a first-line option for seizures and epilepsy
A policy-focused review arguing that biofeedback and neurofeedback deserve a place as first-line treatments for epilepsy. It points out that many people still have seizures despite medication or surgery, and frames epilepsy as a problem of brain networks that self-regulation training can address safely and at low cost. A review of the literature from the 1960s onward found 150 articles reporting fewer seizures and improved EEG or QEEG findings, and the author calls on clinicians, insurers and the public to support these approaches.